Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Exosome capable of targeting and blocking chemokine receptor as well as preparation method and application of exosome

A chemokine receptor and exosome technology, applied in the field of cell biology, can solve the problems of poor efficacy and poor targeting of anti-inflammatory drugs, achieve inhibition of chemokine signals, reduce inflammatory cell infiltration, improve The effect of the local microenvironment

Active Publication Date: 2021-07-13
THE FIRST AFFILIATED HOSPITAL OF BENGBU MEDICAL COLLEGE
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The technical problem to be solved by the present invention is that the existing anti-inflammatory drugs have poor curative effect and poor targeting

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Exosome capable of targeting and blocking chemokine receptor as well as preparation method and application of exosome
  • Exosome capable of targeting and blocking chemokine receptor as well as preparation method and application of exosome
  • Exosome capable of targeting and blocking chemokine receptor as well as preparation method and application of exosome

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Example 1 Construction of Exo membrane component Lamp2b and broad-spectrum chemokine receptor binding peptide vMIP-II fusion gene expression vector vMIP-II-Lamp2b plasmid

[0044] Referring to the full-length RNA sequence of the chemokine receptor binding peptide vMIP-II in the NCBI gene bank (GeneID: 4961514), the nucleotide sequence encoding the polypeptide was designed, and its amino acid sequence is shown in SEQ ID No.1.

[0045] According to the full-length RNA sequence of the lysosome-associated membrane protein Lamp2b in the NCBI gene bank (GeneID: NM_010685.3), find out the sequence encoding the protein, and insert the nucleotide sequence encoding vMIP-II into the nucleotide encoding Lamp2b In the sequence, the specific position is located after 129 nucleotides downstream of the start codon of the nucleotide sequence of Lamp2b, thereby constituting the vMIP-II-Lamp2b fusion gene. The full sequence length of the fusion gene is 1008bp, and the tail end of the Lamp2...

Embodiment 2

[0069] Example 2 Establishment of a cell line stably expressing vMIP-II-Lamp2b fusion protein

[0070] Main experimental materials and instruments: plasmid extraction kit (Qiagen, cat.no.12263); tissue culture 6-well plate (Nunclon, cat.no.140685); biological safety cabinet (Thermo); cell culture box (Thermo) ; fluorescence microscope (Nikon); ABI PRISM7500 real-time PCR System; human embryonic kidney cells HEK293T; DMEM highglucose (GIBCO, cat.no.11995); FBS, heat inactivated (GIBCO, cat.no.26140-079); Glutamax (GIBCO, cat.no.35050); Penicillin-Streptomycin (GIBCO, cat.no.15140-122); Pancreatin-EDTA, 0.25% (GIBCO, cat.no.3197); Calcium-magnesium-free phosphate Buffer (GIBCO, cat.no.14190); Hank's balanced salt solution, 1× (GIBCO, cat.no.14025-092); HEPES (Sigma, cat.no.H4034); Opti-MEM (GIBCO, cat .no.31985); pCMV-dR8.9, purchased from Addgene; pCMV-VSV-G, purchased from Addgene.

[0071] HEK293T cells (ATCC No.CRL-11268) must be selected to be in the vigorous growth perio...

Embodiment 3

[0077] Example 3 qPCR identification of vMIP-II-Lamp2b gene overexpression effect

[0078] Main reagents and instruments: PureLink TM Genomic DNA Mini Kit (Invitrogen TM , K182001); 2XSG Fast qPCR master mix (BBI company, B639271); Thermo Fisher nanodrop one ultra-trace nucleic acid analyzer; Bio-Rad CFX96 fluorescence quantitative PCR instrument.

[0079] Collect cells, press PureLink TM Genomic DNA Mini Kit manual to extract cellular DNA. Measure the DNA concentration with a Thermo Fisher nanodrop one ultra-micro nucleic acid analyzer; configure the PCR reaction system according to Table 6. The PCR instrument was used for the reaction, and the cycle conditions were as follows: 95°C for 3min; 95°C for 3sec, 60°C for 30sec, 30 cycles; 4°C for storage. The primers used are listed in Table 7. Quantitative values ​​and analysis using 2 -ΔΔ Ct analysis. The result is as Figure 8 As shown, it indicates that the HEK293T cell line stably expressing vMIP-II-Lamp2b highly expr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of cell biology, and particularly relates to an exosome capable of targeting and blocking a chemokine receptor as well as a preparation method and an application of the exosome. The invention aims to solve the technical problems that the existing anti-inflammatory drug is poor in curative effect and poor in targeting property. The invention provides the exosome capable of targeting and blocking a chemokine receptor. A lysosome related membrane protein 2b (Lamp2b) and a virus macrophage inflammation protein II (vMIP-II) are subjected to fusion expression. The exosome not only has the characteristics of common Exo, but also can target an inflammatory site rich in chemokine receptors through vMIP-II, so that the effects of inhibiting chemokine signals, reducing inflammatory cell infiltration and improving a local microenvironment are achieved, and the exosome has important significance on clinical treatment of central nervous system (CNS) inflammation related diseases.

Description

technical field [0001] The invention belongs to the technical field of cell biology, and in particular relates to an exosome capable of targeting and blocking chemokine receptors and its preparation method and application. Background technique [0002] Central nervous system (CNS) inflammatory diseases can be caused by infection, trauma, autoimmunity and other factors. Their common features are the activation and increase of local inflammation-related cells and the infiltration of peripheral inflammatory cells, leading to the increase of inflammatory factors, the formation of an inflammatory microenvironment, and ultimately organ dysfunction. Therefore, using appropriate methods to give anti-inflammatory therapy as early as possible and improve the local microenvironment of the central nervous system is an important strategy for the treatment of related diseases. [0003] At present, there are many basic and clinical studies on anti-inflammatory regimens, which can be summa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/10C12N15/85C12N15/65C12N15/62A61K48/00A61K38/19A61P25/00
CPCC12N5/0686C12N15/85C12N15/65C07K14/70596C07K14/522A61K48/0058A61K48/0008A61K38/195A61P25/00C12N2510/00C12N2800/107C12N2509/00C07K2319/00C07K2319/60
Inventor 吕合作胡建国李璟璐陈雨晴丁淑琴
Owner THE FIRST AFFILIATED HOSPITAL OF BENGBU MEDICAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com